(Press-News.org) MSU has a satellite uplink/LTN TV studio and Comrex line for radio interviews upon request.
EAST LANSING, Mich. – Randomized controlled trials, or RCTs, are believed to be the best way to study the safety and efficacy of new treatments in clinical research. However, a recent study from Michigan State University found that people of color and white women are significantly underrepresented in RCTs due to systematic biases.
The study, published in the Journal of Ethnicity in Substance Abuse, reviewed 18 RCTs conducted over the last 15 years that tested treatments for post-traumatic stress and alcohol use disorder. The researchers found that despite women having double the rates of post-traumatic stress and alcohol use disorder than men, and people of color having worse chronicity than white people, most participants were white (59.5%) and male (about 78%).
“Because RCTs are the gold standard for treatment studies and drug trials, we rarely ask the important questions about their limitations and failings,” said Nicole Buchanan, co-author of the study and professor in MSU’s Department of Psychology. “For RCTs to meet their full potential, investigators need to fix barriers to inclusion. Increasing representation in RCTs is not simply an issue for equity, but it is also essential to enhancing the quality of our science and meeting the needs of the public that funds these studies through their hard-earned tax dollars.”
The researchers found that the design and implementation of the randomized controlled trials contributed to the lack of representation of people of color and women. This happened because trials were conducted in areas where white men were the majority demographic group and study samples almost always reflected the demographic makeup where studies occurred. Additionally, those designing the studies seldom acknowledged race or gender differences, meaning they did not intentionally recruit diverse samples.
Furthermore, the journals publishing these studies did not have regulations requiring sample diversity, equity or inclusion as appropriate to the conditions under investigation.
“Marginalized groups have unique experiences from privileged groups, and when marginalized groups are poorly included in research, we remain in the dark about their experiences, insights, needs and strengths,” said Mallet Reid, co-author of the study and doctoral candidate in MSU’s Department of Psychology. “This means that clinicians and researchers may unknowingly remain ignorant to how to attend to the trauma and addiction challenges facing marginalized groups and may unwittingly perpetuate microaggressions against marginalized groups in clinical settings or fail to meet their needs.”
Read on MSUToday.
By Shelly DeJong
###
Michigan State University has been advancing the common good with uncommon will for more than 165 years. One of the world’s leading public research universities, MSU pushes the boundaries of discovery to make a better, safer, healthier world for all while providing life-changing opportunities to a diverse and inclusive academic community through more than 400 programs of study in 17 degree-granting colleges.
For MSU news on the web, go to MSUToday or x.com/MSUnews.
END
New MSU study finds systematic biases at play in clinical trials
2024-07-02
ELSE PRESS RELEASES FROM THIS DATE:
Nuclear spectroscopy breakthrough could rewrite the fundamental constants of nature
2024-07-02
Key takeaways
Raising the energy state of an atom’s nucleus using a laser, or exciting it, would enable development of the most accurate atomic clocks ever to exist. This has been hard to do because electrons, which surround the nucleus, react easily with light, increasing the amount of light needed to reach the nucleus.
By causing the electrons to bond with fluorine in a transparent crystal, UCLA physicists have finally succeeded in exciting the neutrons in a thorium atom’s nucleus using a moderate amount of laser light.
This accomplishment means that measurements of time, gravity and other fields that are currently performed ...
Groundbreaking University of Alberta study discovers connection between between heart and brain in KBG syndrome
2024-07-02
EDMONTON — A new groundbreaking study sheds light on a medical question scientists have long wondered: why do 40 per cent of children with the rare neurodevelopmental disorder KBG syndrome have heart defects? The research now points to a critical link between the heart and the brain.
KBG syndrome can cause unusual facial development, skeletal abnormalities, intellectual underdevelopment and heart defects. The syndrome is caused by mutations in the ANKRD11 gene, which plays a crucial role in brain development, but it wasn’t until now ...
Optoelectronics gain spin control from chiral perovskites and III-V semiconductors
2024-07-02
A research effort led by scientists at the U.S. Department of Energy’s (DOE’s) National Renewable Energy Laboratory (NREL) has made advances that could enable a broader range of currently unimagined optoelectronic devices.
The researchers, whose previous innovation included incorporating a perovskite layer that allowed the creation of a new type of polarized light-emitting diode (LED) that emits spin-controlled photons at room temperature without the use of magnetic fields or ferromagnetic contacts, now have gone a step further by integrating a III-V semiconductor ...
Doctors could soon use facial temperature for early diagnosis of metabolic diseases
2024-07-02
A colder nose and warmer cheeks may be a telltale sign of rising blood pressure.
Researchers discovered that temperatures in different face regions are associated with various chronic illnesses, such as diabetes and high blood pressure. These temperature differences are not easily perceptible by one’s own touch but can instead be identified using specific AI-derived spatial temperature patterns that require a thermal camera and a data-trained model. The results appear July 2 in the journal Cell Metabolism. With ...
Engineered plasma cells show long-lasting antileukemic activity in mice
2024-07-02
Researchers show for the first time that engineered human plasma B cells can be used to treat a disease—specifically leukemia—in a humanized animal model. The results mark a key step in the realization of ePCs as therapies to treat cancer, auto-immune disorders, and protein deficiency disorders. The results appear July 2 in the journal Molecular Therapy.
“We hope that this proof-of-concept study is the first of many applications of engineered plasma B cells, and eventually will lead to a single-shot therapeutic,” says senior study author Richard James (@ScienceRicker) of the Seattle Children’s ...
Proteins and fats can drive insulin production for some, paving way for tailored nutrition
2024-07-02
When it comes to managing blood sugar levels, most people think about counting carbs. But new research from the University of British Columbia shows that, for some, it may be just as important to consider the proteins and fats in their diet.
The study, published today in Cell Metabolism, is the first large-scale comparison of how different people produce insulin in response to each of the three macronutrients: carbohydrates (glucose), proteins (amino acids) and fats (fatty acids).
The findings reveal that production of the blood sugar-regulating hormone insulin is much more dynamic and individualized than previously ...
Melting of Alaskan glaciers accelerating faster than previously thought
2024-07-02
Melting of glaciers in a major Alaskan icefield has accelerated and could reach an irreversible tipping point earlier than previously thought, new research suggests.
The research, led by scientists at Newcastle University, UK, found that glacier loss on Juneau Icefield, which straddles the boundary between Alaska and British Columbia, Canada, has increased dramatically since 2010.
The team, which also included universities in the UK, USA and Europe, looked at records going back to 1770 and identified three distinct periods in how icefield volume changed. They saw that glacier volume loss remained fairly ...
Genetic study points to oxytocin as possible treatment for obesity and postnatal depression
2024-07-02
Scientists have identified a gene which, when missing or impaired, can cause obesity, behavioural problems and, in mothers, postnatal depression. The discovery, reported today in Cell, may have wider implications for the treatment of postnatal depression, with a study in mice suggesting that oxytocin may alleviate symptoms.
Obesity and postnatal depression are significant global health problems. Postnatal depression affects more than one in 10 women within a year of giving birth and is linked to an increased risk of ...
What was behind the 2021-2022 energy crisis within Europe?
2024-07-02
WASHINGTON, July 2, 2024 – An energy crisis hit Europe in 2021-2022, following Russia’s invasion of Ukraine, which sent electricity prices skyrocketing — even within countries that don’t rely on Russian gas. It begs the question: Was there more to it?
A team of researchers from the Institute for Energy and Climate Research at Forschungszentrum Jülich, the University of Cologne, and the Norwegian University of Life Sciences had already been working with electricity price data for years, exploring statistics and developing forecasting methods. Adopting a European perspective, ...
Alterations in human gene TRPC5 cause obesity and postpartum depression
2024-07-02
Researchers at Baylor College of Medicine, the University of Cambridge and collaborating institutions have discovered that alterations in the human gene TRPC5 cause obesity and postpartum depression.
Taken together, their studies in cells, animal models and humans showed that TRPC5 acts on distinct neuronal populations in the hypothalamus, a brain region that regulates multiple innate behaviors including feeding, anxiety, socialization and maternal care. The findings, published in the journal Cell, ...